Novel Pt@BSA nanoparticles improve radiotherapeutic outcomes in breast cancer
Abstract
studies indicated that Pt@BSA-RM combined with X-ray irradiation markedly suppressed tumor growth compared with monotherapy, with reduced systemic toxicity. These results indicated that the red blood cell membrane-coated Pt@BSA nanoparticles effectively improve radiotherapeutic outcomes in breast cancer by enhancing the cellular radiosensitivity and minimizing the adverse effects. This biomimetic nanoplatform holds promise for further translational research in cancer radiotherapy.
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Radiation Therapy and Dosimetry
Publication details
- Journal / source
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 17
- Issue
- 2
- Pages
- 1187–1199
- Publication date
- 1 January 2026
- Language
- EN